The Newsroom

Investigations  /  05.21.2020

Investigation of Personalis, Inc.

You Have Legal Options

Shareholder Alert: Robbins LLP Reminds Investor It Is Investigating the Officers and Directors of Personalis, Inc. (PSNL) on Behalf of Shareholders

May 20, 2020 (San Diego, CA & Menlo Park, CA) – Shareholder rights law firm Robbins LLP reminds investors it is investigating Personalis, Inc. (NYSE: PSNL) for potential violations of federal securities laws pursuant to its June 2019 initial public offering (“IPO”). Personalis completed its IPO on June 20, 2019, offering shares at $17.00 and raising $140 million in gross proceeds. Four days after the IPO, Personalis stock was trading as high as $31.88 per share. However, by April 27, 2020, shares of Personalis closed at $10.31 per share, representing a decline of almost 40% from its IPO price and a decline of 67% from its record high of $31.88 per share. The stock has yet to recover. Personalis operates as a cancer genomics company worldwide.

  • If you would like more information about your rights and potential remedies please send us a message. 

  • Please Note: Neither the submission to nor the receipt of information by Robbins LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1 800 350 6003 or [email protected]

Tell us your concerns